Swedish Life Sciences Stock News

If you are wondering whether Telefonaktiebolaget LM Ericsson’s current share price fairly reflects its potential, you are not alone. Many investors are asking the same question before making their next move. The stock last closed at SEK 97.2, with returns of a 2.3% decline over 7 days, 11.7% over 30 days, 10.1% year to date, 18.1% over 1 year, 81.0% over 3 years and 5.8% over 5 years. This gives investors plenty to think about in terms of changing sentiment and risk. Recent news coverage...

As the European markets continue to show resilience amid global volatility, optimism about the eurozone economy has supported investor sentiment, with major indices like Germany's DAX and France's CAC 40 posting gains. In this environment of cautious optimism and stable interest rates from the European Central Bank, identifying undervalued stocks becomes crucial for investors looking to capitalize on potential market opportunities.

There's been a notable change in appetite for Asker Healthcare Group AB ( STO:ASKER ) shares in the week since its...

Scandi Standard AB (publ) ( STO:SCST ) shareholders have had their patience rewarded with a 27% share price jump in the...

The Tele2 AB (publ) ( STO:TEL2 B ) share price has done very well over the last month, posting an excellent gain of...

Sandvik AB (publ)'s ( STO:SAND ) dividend will be increasing from last year's payment of the same period to SEK6.00 on...

While it may not be enough for some shareholders, we think it is good to see the Elekta AB (publ) ( STO:EKTA B ) share...

The board of Vitec Software Group AB (publ) ( STO:VIT B ) has announced that it will pay a dividend of SEK0.90 per...

JLT Mobile Computers AB (publ) ( STO:JLT ) shareholders that were waiting for something to happen have been dealt a...

Hansa Biopharma (OM:HNSA) has reported full year 2025 results with fourth quarter revenue of SEK 76.0 million and a basic EPS loss of SEK 1.62, alongside a trailing twelve month EPS loss of SEK 6.52 on revenue of SEK 222.3 million. The company has seen quarterly revenue move between SEK 30.8 million and SEK 76.0 million across 2025, while quarterly basic EPS stayed in loss-making territory, ranging from SEK 0.55 to SEK 2.53 per share. For investors, the latest print keeps the focus squarely...

As the European market continues to show resilience amidst global volatility, with the pan-European STOXX Europe 600 Index reaching new highs and major indexes like Germany's DAX and France's CAC 40 posting gains, investors are increasingly optimistic about the eurozone economy. In this environment of cautious optimism, dividend stocks can offer a compelling opportunity for income-focused investors seeking stability and potential returns; these stocks typically provide regular payouts that...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

To the annoyance of some shareholders, Surgical Science Sweden AB (publ) ( STO:SUS ) shares are down a considerable 25...

Key Insights Bonesupport Holding's estimated fair value is kr293 based on 2 Stage Free Cash Flow to Equity Current...

Nobia AB (publ) ( STO:NOBI ) shares have had a horrible month, losing 27% after a relatively good period beforehand...

AddLife AB (publ)'s ( STO:ALIF B ) stock was strong after they recently reported robust earnings. We did some analysis...

Over the past year, insiders sold kr14m worth of Cheffelo AB (publ) ( STO:CHEF ) stock at an average price of kr37.96...

Thule Group FY 2025 Earnings Snapshot Thule Group (OM:THULE) has wrapped up FY 2025 with Q4 revenue of SEK 1.8b and basic EPS of SEK 0.19, alongside trailing twelve month revenue of SEK 10.4b and EPS of SEK 10.33. The company reported quarterly revenue of SEK 2.7b in Q1 2025, SEK 3.4b in Q2, SEK 2.5b in Q3 and SEK 1.8b in Q4, while EPS over the same periods came in at SEK 2.47, SEK 4.75, SEK 2.91 and SEK 0.19. This provides context for investors assessing how margins have developed over the...

Asker Healthcare Group (OM:ASKER) FY 2025 Results Snapshot Asker Healthcare Group (OM:ASKER) has wrapped up FY 2025 with fourth quarter revenue of SEK4.7 billion and basic EPS of 0.34 SEK, setting the tone for how investors assess the full year. Over recent periods, the company has seen quarterly revenue move from SEK4.3 billion and EPS of 0.24 SEK in Q4 2024 to SEK4.7 billion and EPS of 0.34 SEK in Q4 2025. Trailing twelve month EPS came in at 1.25 SEK on revenue of SEK16.8 billion, giving...

Alimak Group (OM:ALIG) has wrapped up FY 2025 with fourth quarter revenue of SEK 1,692 million and basic EPS of SEK 0.98, setting the tone for how investors will parse the full year. The company has seen quarterly revenue move between SEK 1,658 million and SEK 1,791 million through 2025, with EPS ranging from SEK 0.98 to SEK 1.74. Trailing twelve month EPS for the period ended Q4 2025 is SEK 5.71. With trailing net margin at 9.9% and recent earnings growth in the backdrop, this latest print...

In February 2026, global markets are experiencing a dynamic shift as small-cap and value-oriented stocks make gains amid a cooling U.S. labor market and volatility in large-cap technology shares. With the S&P MidCap 400 and Russell 2000 indices showing solid performance, investors are increasingly interested in small-cap opportunities that demonstrate resilience and potential for growth. In this context, identifying a good stock often involves looking at companies with strong fundamentals...

Key Insights Institutions' substantial holdings in Intea Fastigheter implies that they have significant influence over...

Medicover AB (publ)'s ( STO:MCOV B ) price-to-earnings (or "P/E") ratio of 46.4x might make it look like a strong sell...